Why Abzena?
Our focused approach.
Through a comprehensive technology transfer program, we deliver a successful scale-up model to ensure robust and consistent bioconjugate manufacturing process from clinical to commercial scale.
We collaborate with your team to de-risk the pathway to commercialization, ensure manufacturability, and deliver a quality medicine to the patient.
Promoting innovation and continuous improvement we adhere to a framework following ICH guidance and work collaboratively alongside you, to support the management of post approval Chemistry and Manufacturing Control (CMC) changes for your product.
Abzena has extensive capabilities in cGMP and non-GMP production and expertise in employing single-use technology allows for rapid turnaround times and cost-effective solutions.
Supporting the robust scaling of your project from clinical through to commercial scale, we are dedicated to manufacturing excellence, delivering small molecule intermediates including bioconjugates and antibody-drug conjugates (ADCs).